Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis

详细信息    查看全文

• 作者：Hai-Wei Xie ; Qing-Quan Wu ; Bin Zhu ; Fang-Jun Chen ; Lv Ji ; Su-Qing Li…
• 关键词：SPRY4 ; IT1 ; Long noncoding RNA ; Esophageal squamous cell carcinoma ; Proliferation ; Migration ; Invasion
• 刊名：Tumor Biology
• 出版年：2014
• 出版时间：August 2014
• 年：2014
• 卷：35
• 期：8
• 页码：7743-7754
• 全文大小：1,615 KB
• 参考文献：1. Kamangar F, Doers GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137-0. CrossRef
  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Cancer J Clin. 2011;61:69-0. CrossRef
  3. Matsushima K, Isomoto H, Kohno S, Nakao K. MicroRNAs and esophageal squamous cell carcinoma. Digestion. 2010;82:138-4. CrossRef
  4. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discuter. 2011;1:391-07. CrossRef
  5. Tang F, Zhang R, He Y, Zou M, Guo L, Xi T. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS One. 2012;7:e35435. CrossRef
  6. Jang J, Jeon HS, Sun Z, Aubry MC, Tang H, Park CH, et al. Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma in non smokers. Clin Cancer Res. 2012;18:3658-7. CrossRef
  7. Xu K, Liang X, Shen K, Cui D, Zheng Y, Xu J, et al. MiR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2. Biochem J. 2012;446:291-00. CrossRef
  8. Buurman R, Gürlevik E, Sch?ffer V, Eilers M, Sandbothe M, Kreipe H, et al. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology. 2012;143:811-0. CrossRef
  9. Zhao X, Dou W, He L, Liang S, Tie J, Liu C, et al. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene. 2012;32:1363-2. CrossRef
  10. Li SQ, Wang HM, Cao XF. Potential clinical insights into microRNAs and their target genes in esophageal carcinoma. Biomarkers. 2011;16:629-6. CrossRef
  11. Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011;71:3-. CrossRef
  12. Pauli A, Rinn JL, Schier AF. Non-coding RNAs as regulators of embryogenesis. Nat Rev Genet. 2011;12:136-9. CrossRef
  13. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482:339-6. CrossRef
  14. Flockhart RJ, Webster DE, Qu K, Mascarenhas N, Kovalski J, Kretz M, et al. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res. 2012;22:1006-4. CrossRef
  15. Silva JM, Boczek NJ, Berres MW, Ma X, Smith DI. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011;8:496-05. CrossRef
  16. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acid Res. 2010;38:5366-3. CrossRef
  17. Chen FJ, Sun M, Li SQ, Wu QQ, Ji L, Liu ZL, et al. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcin. 2012;52:908-5. CrossRef
  18. Lv XB, Lian GY, Wang HR, Song E, Yao H, Wang MH. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One. 2013;8:e63516. CrossRef
  19. Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS, et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Resh. 2011;71:3852-2. CrossRef
  20. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer. 1992;69:277-4. CrossRef
  21. Kanda Y, Nishiyama Y, Shimada Y, Imamura M, Nomura H, Hiai H, et al. Analysis of gene amplification and over expression in human esophageal carcinoma cell lines. Int J Cancer. 1994;58:291-. CrossRef
  22. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013;32:1616-5. CrossRef
  23. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155-. CrossRef
  24. Ponjavic J, Ponting C, Lunter G. Functionality or transcriptional noise? Evidence for selection of long non coding RNAs. Genome Res. 2007;17:556-5. CrossRef
  25. Struhl K. Transcriptional noise and the fidelity of initiation by RNA polymerase II. Nat Struct Mol Biol. 2007;14:103-. CrossRef
  26. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research. Oncogene. 2012;31:4577-7. CrossRef
  27. Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012;40:6391-00. CrossRef
  
• 作者单位：Hai-Wei Xie (1)
  Qing-Quan Wu (2)
  Bin Zhu (1)
  Fang-Jun Chen (3)
  Lv Ji (1)
  Su-Qing Li (1)
  Chun-Mei Wang (1)
  Yu-Suo Tong (1)
  Lei Tuo (1)
  Ming Wu (4)
  Zhi-Hua Liu (5)
  Jin Lv (1)
  Wei-Hong Shi (6)
  Xiu-Feng Cao (1)
  
  1. Department of Surgical Oncology, Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
  2. Department of Thoracic Surgery, Huaian Hospital Affiliated to Nanjing Medical University, Huaian, Jiangsu, China
  3. Department of Oncology, Changzhou Second Hospital Affiliated to Nanjing Medical University, Changzhou, Jiangsu, China
  4. Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China
  5. State Key Laboratory of Molecular Oncology, Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China
  6. Department of Medical Technology, Yancheng Health Vocational and Technical College, Yancheng, Jiangsu, China
  
• ISSN：1423-0380

文摘

LncRNA SPRY4-IT1 has been shown to promote the progression of melanoma. However, the role of lncRNA SPRY4-IT1 in human esophageal squamous cell carcinoma (ESCC) remains unclear. The purpose of this study is to investigate the clinical significance and biological functions of SPRY4-IT1 in ESCC. The expression levels of lncRNA SPRY4-IT in 92 ESCC patients and 8 ESCC cell lines were evaluated by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). The prognostic significance was evaluated using Kaplan–Meier and Cox regression analyses. Small interfering RNA (siRNA) was used to suppress SPRY4-IT1 expression in ESCC cell lines. Both in vitro and in vivo assays were performed to further explore its role in tumor progression. SPRY4-IT1 levels were significantly higher in ESCC tissues and cells than in corresponding adjacent noncancerous tissues and nontumorigenic esophageal epithelial cells, and the ESCC patients with higher SPRY4-IT1 expression had an advanced clinical stage and poorer prognosis than those with lower SPRY4-IT1 expression. The multivariate analysis revealed that SPRY4-IT1 expression level is an independent prognostic factor in ESCC patients. In vitro assays demonstrated that knockdown of SPRY4-IT1 reduced cell proliferation, invasiveness, and migration. In vivo assays demonstrated that knockdown of SPRY4-IT1 decreases cell growth. SPRY4-IT1 is a novel molecule involved in ESCC progression, which may provide a potential prognostic biomarker and a potential target for therapeutic intervention.